Home Biosimilar Antibodies Immunology & Inflammation Interleukins antibody Perakizumab (Anti-CTLA-8 / IL-17a) For research use only.
Not for use in humans.

Perakizumab (Anti-CTLA-8 / IL-17a)

Synonyms: RG4934

Perakizumab (Anti-CTLA-8 / IL-17a) is a humanized IgG1κ monoclonal antibody against interleukin-17A (IL-17A). MW: 145.8 KD.

Perakizumab (Anti-CTLA-8 / IL-17a)

Purity & Quality Control

≥99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Perakizumab (Anti-CTLA-8 / IL-17a) is a humanized IgG1κ monoclonal antibody against interleukin-17A (IL-17A). MW: 145.8 KD.

Product Details

CAS No. 1331830-76-2
Molecular Weight 145.8
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Perakizumab (Anti-CTLA-8 / IL-17a) | Perakizumab (Anti-CTLA-8 / IL-17a) supplier | purchase Perakizumab (Anti-CTLA-8 / IL-17a) | Perakizumab (Anti-CTLA-8 / IL-17a) cost | Perakizumab (Anti-CTLA-8 / IL-17a) manufacturer | order Perakizumab (Anti-CTLA-8 / IL-17a) | Perakizumab (Anti-CTLA-8 / IL-17a) distributor